Deferred Tax Assets, Net of Valuation Allowance of Accelerate Diagnostics, Inc from 31 Jul 2012 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: Accelerate Diagnostics, Inc quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Jul 2012 to 31 Dec 2024.
Accelerate Diagnostics, Inc Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $5,502,000, a 34% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Accelerate Diagnostics, Inc Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$5,502,000	-$2,819,000	-34%	31 Dec 2024	10-K	21 Mar 2025	2024	FY
Q4 2023	$8,321,000	+$7,687,000	+1212%	31 Dec 2023	10-K	21 Mar 2025	2024	FY
Q4 2022	$634,000	-$2,992,000	-83%	31 Dec 2022	10-K	29 Mar 2024	2023	FY
Q4 2021	$3,626,000	-$4,351,000	-55%	31 Dec 2021	10-K	31 Mar 2023	2022	FY
Q4 2020	$7,977,000	-$2,695,000	-25%	31 Dec 2020	10-K	14 Mar 2022	2021	FY
Q4 2019	$10,672,000	-$1,360,000	-11%	31 Dec 2019	10-K	02 Mar 2021	2020	FY
Q4 2018	$12,032,000	+$12,032,000		31 Dec 2018	10-K	28 Feb 2020	2019	FY
Q4 2017	$0			31 Dec 2017	10-K	01 Mar 2019	2018	FY
Q4 2012	$1,000^*			31 Dec 2012	10-K	07 Mar 2014	2013	FY
Q2 2012	$8,875^*			31 Jul 2012	10-KT	20 Mar 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.